Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
Ross Baker, Professor at The University of Notre Dame Australia, Founding Chair of Perth Blood Institute, Professor and Director at Western Australian Centre for Thrombosis and Haemostasis (WACTH) Murdoch University, Director of Hollywood Hospital Haemophilia Treatment Centre, shared a post on LinkedIn:
“Heavy menstrual bleeding and inherited bleeding disorders are leading causes of iron deficiency—often missed and undertreated.
The new ASH 2026 guidelines recommend screening all women with HMB or inherited bleeding disorders for iron deficiency using a higher ferritin threshold of 50 ng/mL or less—especially before anaemia develops. Early diagnosis and treatment can improve quality of life and health outcomes.
The Perth Blood Institute is launching a women’s blood health initiative in November to boost awareness and best practices for iron deficiency in people affected by heavy menstrual bleeding and bleeding disorders.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:50Rainer Kaiser: Genes and Signalling Pathways Implicated in Procoagulant Platelet Generation
-
Sep 21, 2026, 20:49Natalia Dovlatova: Celebrating Stan Heptinstall and His Legacy in Platelet Science
-
Sep 21, 2026, 20:48Norm Roulet: The Interaction of Pb and SARS-CoV-2 and Its Impact on the Cardiovascular System
-
Sep 21, 2026, 20:45Felix Scholkmann: The Spleen Plays a Key Role in Regulating Platelet Activity
-
Sep 21, 2026, 20:43Claire Pomeroy: Celebrating the 2026 Lasker Awards and Why Medical Research Matters
-
Sep 21, 2026, 20:42Fiona Robinson: Practical Information for People With Hemophilia and Inhibitors